I agree with you Next, I think this demonstrates that Eastern and Hepalink are still behind the science. Further to that I'd be willing to bet that Bloom Burton could have sold more units in the pp if their clients had known Eastern and Hepalink were going to participate. 

Wrt the $117MM "typo" it makes me think that management may still be working on something but if that doesn't pan out we may see the loan increased to the $117MM level. Seat of the pants the numbers would seem to make sense. I would still like to see the company address the "typo" directly and tell us which slide was used in the presentation and what the talking points were around that slide.